ADAR1 Capital Management »

Boston Scientific Corporation shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Boston Scientific Corporation (BSX) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Boston Scientific Corporation

Tip: Access up to 7 years of quarterly data

All positions including Boston Scientific Corporation held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Boston Scientific Corporation by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $477k 5.0k 95.35
2024-09-30 $210k 2.5k 83.80

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Avidity Biosciences Ord (RNA)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Arbutus Biopharma (ABUS)
Zai Lab Adr (ZLAB)
Terns Pharmaceuticals (TERN)
Cytomx Therapeutics (CTMX)
Celldex Therapeutics Com New (CLDX)
Rapt Therapeutics Com New (RAPT)

View all positions for ADAR1 Capital Management

Top funds holding Boston Scientific Corporation

Vanguard Group
BlackRock
FMR
State Street Corporation
Geode Capital Management
PRIMECAP Management Company
Jpmorgan Chase & Co
Capital World Investors
Norges Bank Investment Management
Bollard
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Goldman Sachs Group
UBS Group
Wellington Management Company
Northern Trust

View all funds holding Boston Scientific Corporation